Time to completion of conditions required by Health Canada after approving new drugs: A cohort study

Joel Lexchin

Health Policy, 2025, vol. 155, issue C

Abstract: To ensure that promising drugs for serious illnesses reach Canadians in a timely manner, Health Canada can approve them conditionally provided companies commit to conducting confirmatory studies to verify the benefits.

Keywords: Conditional approval; Fulfillment; Health canada; New drug; New indication; Orphan status; Qualifying notice (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851025000703
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:155:y:2025:i:c:s0168851025000703

DOI: 10.1016/j.healthpol.2025.105314

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().